La cadena de opciones muestra datos clave de las opciones de acciones de Lucid Diagnostics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Lucid Diagnostics..

Lucid Diagnostics (NASDAQ:LUCD) Bolsa, Cadena de Opciones

LUCID DIAGNOSTICS INC

Lucid Diagnostics

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

<a target="_blank" href="https://www.benzinga.com/topic/ai-stocks" rel="noreferrer noopener">Artificial intelligence (AI) chip stocks</a>, including industry giants like Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), and Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), alongside key players such as Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Arm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), Marvell Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), and Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), saw a significant surge in their stock prices on Tuesday.
This market uptick was primarily driven by two major developments: reports indicating the Trump administration&#8217;s plans to announce substantial AI and energy investments in Pennsylvania, and the U.S. government&#8217;s decision to lift certain chip export restrictions to China.
President Donald Trump is set to unveil a major initiative on Tuesday near Pittsburgh, detailing plans for approximately $70 billion in new investments in artificial intelligence and energy infrastructure.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46295574/nvidia-outpaces-market-with-ai-powered-growth" rel="noreferrer noopener">Nvidia Outpaces Market With AI-Powered Growth, Nears Record Highs</a>
Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-14/trump-to-unveil-70-billion-in-ai-and-energy-investments?sref=TBDibEcD" rel="noreferrer noopener">reported</a> on Monday that this comprehensive plan encompasses the development of new AI data centers, the expansion of power generation capabilities, critical upgrades to grid infrastructure, and the introduction of new training programs and apprenticeships.
This announcement represents a pivotal move in Trump&#8217;s broader strategy to bolster America&#8217;s leadership in AI by actively encouraging private investment, streamlining regulatory processes, and expediting permits for both technology and energy projects.
The event, hosted by Senator David McCormick at Carnegie Mellon University, is expected to draw a distinguished gathering of around 60 top executives from various sectors, including leaders from BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), Anthropic, ExxonMobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), and Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>).
Further underscoring the magnitude of these investments, Blackstone President Jon Gray is anticipated to announce a $25 billion initiative specifically targeting data center and energy infrastructure expansion.
This project is projected to generate thousands of construction and permanent jobs, contributing significantly to the economy. This follows earlier announcements made under Trump&#8217;s second term, notably a staggering $100 billion AI investment pledge from a consortium including SoftBank (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>), OpenAI, and Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>).
These strategic moves, alongside the recent rollback of Biden-era AI chip restrictions, are explicitly aimed at counteracting China&#8217;s aggressive advancements in AI and maintaining the United States&#8217; technological superiority on the global stage.
Adding to the positive momentum for Nvidia and other chip stocks was the U.S. government&#8217;s recent decision to ease chip <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46409079/nvidia-growth-estimates-get-10-boost-as-us-lifts-china-chip-export-curbs-gene-munster-predicts-30-35-growth-for-2026" rel="noreferrer noopener">export restrictions to China</a>. This move is particularly impactful for companies like Nvidia, which had faced significant revenue setbacks due to previous bans.
Gene Munster, managing partner at Deepwater Asset Management, expressed optimism, stating that Wall Street analysts are likely to raise Nvidia&#8217;s growth estimates by approximately 10% following this development.
While acknowledging that some analysts might have already factored in the return of Nvidia&#8217;s H20 chips to the Chinese market, Munster still anticipates a boost to overall forecasts, emphasizing that, &#8220;Either way you look at it, great news for $NVDA.&#8221;
This is especially relevant given that Nvidia had previously incurred a substantial $4.5 billion charge in the first quarter of this year, directly attributable to the export ban on its H20 products to China, which was enforced on April 9.
NVDA Price Action: NVDA stock is trading higher by 4.69% to $171.75 premarket at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45587680/emergence-of-ualink-as-a-viable-alternative-could-challenge-nvidias-dominance-analyst-asserts" target="_blank" rel="noreferrer noopener">Emergence Of UALink As A Viable Alternative Could Challenge Nvidia&#8217;s Dominance, Analyst Asserts</a></li>
</ul>
Image via Shutterstock

Government

News

Movers

Tech

Media

AVGO

MRVL

NVDA

ORCL

PLTR

SFTBF

SFTBY

Trump's Latest Move On AI And China Propels Chip Stocks

<ul>
<li>Eaton power management portfolio and expertise help meet the rapidly expanding infrastructure demands of next-generation data centers</li>
<li>The collaboration with NVIDIA advances Eaton's ability to deliver power management innovation for the full data center ecosystem, from grid to chip</li>
</ul>
Intelligent power management company Eaton today announced that it is enabling the shift to high-voltage direct current (HVDC) power infrastructure in artificial intelligence (AI) data centers. Eaton is collaborating with NVIDIA on design best practices, reference architectures and innovative power management solutions tailored to support high-density GPU deployments, such as NVIDIA Kyber rack-scale systems with NVIDIA Rubin Ultra GPUs. This includes helping <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fprotect.checkpoint.com%2Fv2%2F___https%3A%2Fdeveloper.nvidia.com%2Fblog%2Fnvidia-800-v-hvdc-architecture-will-power-the-next-generation-of-ai-factories%2F___.YzJ1OmVhdG9uY2hlY2twb2ludGhhcm1vbnk6YzpvOjQyNzgyM2Y2MDQ3ODg1ZmQ3M2M0YjYyOGM4ZDAyZmUxOjY6MWFjMTo4YjczYzA1ZGUwNWQ2YzNiZDlhMmUyYzM0NGZmMjRlNzlhY2U4ZmFmNDlmYzAxYzFlOGFjMTdkZTE5ZTNlM2QyOnA6VDpO&amp;esheet=54290479&amp;newsitemid=20250715305964&amp;lan=en-US&amp;anchor=lead+the+transition&amp;index=1&amp;md5=524deef75fa2e254a5508d9d1881c1cf">lead the transition</a> to 800 V HVDC power infrastructure to support 1 megawatt racks and beyond as well as exploring opportunities to leverage its solutions in the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fprotect.checkpoint.com%2Fv2%2F___https%3A%2Fbuild.nvidia.com%2Fnvidia%2Fdigital-twins-for-ai-factories___.YzJ1OmVhdG9uY2hlY2twb2ludGhhcm1vbnk6YzpvOmI3NGVmYTFmZGIyNWViZmE3NmU5NmYzZDc4ZTVmZDdjOjY6MmU3Mjo5YzEyMTUyM2Y0YmFlZGMzNmZlMGFjNWE0MmRmYjMxOGNiMjkwZTlhNTdjYmFmZGE3MDhhZTA0NmM2MTc0Y2MyOnA6RjpO&amp;esheet=54290479&amp;newsitemid=20250715305964&amp;lan=en-US&amp;anchor=NVIDIA+Omniverse+Blueprint+for+AI+factory+design+and+operations&amp;index=2&amp;md5=5a8f392692c3b386ed492167dcb280bd">NVIDIA Omniverse Blueprint for AI factory design and operations</a>.

Eaton Collaborates With NVIDIA On Reference Architectures And Power Management Solutions To Support High-Density GPU Deployments

<ul>
<li>The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg Twice a Week (BIW) and 50% in AML MR with Myelomonocytic/Myelomonoblastic (M4/M5) Subtype</li>
<li>Median Overall Survival (mOS) of 8.9 Months in Patients with AML MR and 8.8 mOS in Relapsed or Refractory to Venetoclax-Based Regimens at 30 mg BIW Dose Level Surpasses the Historical Benchmark of 2.4 Months.</li>
<li>FDA Recommends Advancement towards a Trial Including Newly Diagnosed First-Line AML Patient Cohorts That May Support a New Drug Application; Trial Preparation Underway with Enrollment Expected to Begin by Q1 2026</li>
</ul>

Biotech

Health Care

General

Sellas Life Sciences Says Phase 2 Trial Of SLS009 (Tambiciclib) Met All Primary Endpoints In Relapsed/Refractory Acute Myeloid Leukemia

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Copart Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>)</h3>
<ul class="wp-block-list">
<li>On July 8, Stephens &amp; Co. analyst Jeff Lick initiated coverage on Copart with an Equal-Weight rating and announced a price target of $50. The company's stock fell around 3% over the past five days and has a 52-week low of $46.76.</li>
<li>RSI Value: 29.4</li>
<li>CPRT Price Action: Shares of Copart fell 0.7% to close at $47.13 on Monday.</li>
<li>Edge Stock Ratings: 91.92 Momentum score with Value at 93.51. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/cprt"><img loading="lazy" decoding="async" width="407" height="173" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074014/image-167.png" alt="" class="wp-image-985755" style="width:285px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074014/image-167.png 407w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074014/image-167-300x128.png 300w" sizes="(max-width: 407px) 100vw, 407px" /></a></figure>
<h3 class="wp-block-heading">Fiverr International Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVRR#NYSE">FVRR</a>)&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On May 23, Citigroup analyst Ronald Josey maintained Fiverr Intl with a Buy and raised the price target from $39 to $40.. The company's stock fell around 10% over the past month and <a href="https://www.benzinga.com/quote/FVRR">has a 52-week low</a> of $20.83.</li>
<li>RSI Value: 29.6</li>
<li>FVRR Price Action: Shares of Fiverr International fell 0.8% to close at $27.01 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">FVRR stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="922" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074114/image-168.png" alt="" class="wp-image-985756" style="width:599px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074114/image-168.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074114/image-168-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074114/image-168-768x706.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">Fortive Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>)</h3>
<ul class="wp-block-list">
<li>On July 9, Barclays analyst Julian Mitchell maintained Fortive with an Overweight rating and lowered the price target from $86 to $58.. The company's stock fell around 26% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/FTV">low of $45.49</a>.</li>
<li>RSI Value: 19.9</li>
<li>FTV Ltd Price Action: Shares of Fortive fell 1% to close at $52.17 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">FTV shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="882" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074203/image-169.png" alt="" class="wp-image-985758" style="width:537px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074203/image-169.png 882w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074203/image-169-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074203/image-169-768x717.png 768w" sizes="(max-width: 882px) 100vw, 882px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46408189/jpmorgan-wells-fargo-and-3-stocks-to-watch-heading-into-tuesday">JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

CPRT

FVRR

Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q3

D. Boral Capital analyst Jesse Sobelson maintains Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) with a Buy and maintains $4 price target.

Price Target

Analyst Ratings

VERI

D. Boral Capital Maintains Buy on Veritone, Maintains $4 Price Target

Rosenblatt analyst Mike Genovese maintains Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Buy and maintains $56 price target.

CALX

Rosenblatt Maintains Buy on Calix, Maintains $56 Price Target

SKYQ

Sky Quarry Announces Strategic Initiative To Establish Digital Asset Treasury As Part Of Its Broader Capital Allocation Strategy

WIIM

Nvidia shares are trading higher after the company announced it will resume sales of its H20 GPU to China.

Investment manager giant BlackRock, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) reported&nbsp;that second-quarter 2025 revenue grew&nbsp;13%&nbsp;year-over-year to&nbsp;$5.42 billion, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of&nbsp;$5.34 billion</a>.&nbsp;
Investment advisory, administration fees, and securities lending revenue increased to&nbsp;$4.45 billion from&nbsp;$3.88 billion a year ago, primarily driven by organic base fee growth, the impact of market beta and foreign exchange movements on average AUM, and approximately $240 million of fees related to the GIP Transaction.
Securities lending revenue of $171 million <a target="_blank" href="https://ir.blackrock.com/files/doc_financials/2025/Q2/BLK-2Q25-Earnings-Release.pdf" rel="noreferrer noopener">increased</a> from $154 million in the second quarter of 2024, primarily reflecting higher average balances of securities on loan.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/07/46396595/jpmorgan-citi-to-kick-off-bank-earnings-as-wall-street-sees-profit-boom" rel="noreferrer noopener">JPMorgan, Citi To Kick Off Bank Earnings As Wall Street Sees Profit Boom</a>
Performance fees decreased $70 million from the second quarter of 2024, primarily reflecting lower revenue from private markets, liquid alternative, and long-only products.
BlackRock stated that $68 billion of quarterly total net inflows, down from $81.6 billion a year ago, reflect the impact of a single institutional client&#8217;s $52 billion lower-fee index partial redemption.
Net inflows reached $152 billion year to date, led by a record first half for iShares ETFs, alongside private markets and cash net inflows.
At the end of the quarter, total AUM was $12.53 trillion, compared to&nbsp;$10.65 trillion&nbsp;in the prior year quarter.
Adjusted operating income rose&nbsp;12% to&nbsp;$2.09 billion. Adjusted EPS increased&nbsp;16% to&nbsp;$12.05,&nbsp;beating the consensus of&nbsp;$10.80.
Laurence Fink, Chairman and CEO, commented, &#8220;Our expanding client relationships are resonating in higher, more diversified organic base fee growth. We generated 6% organic base fee growth for the second quarter and the first half of 2025, and 7% over the last twelve months.&#8221;
&#8220;iShares ETFs had a record first half in flows, and technology ACV growth reached a fresh high of 16%. This core strength, alongside client demand for private markets, digital assets, Aperio, and our tech and data-driven systematic strategies, propelled another consecutive quarter of above-target organic base fee growth and record AUM of $12.5 trillion,&#8221; Fink added.
Price Action: BLK stock is trading lower by 1.12% to $1,099 during the premarket session at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46407517/nvidia-resumes-h20-shipments-to-china-as-jensen-huang-meets-trump-beijing-officials-fully-compliant-rtx-pro-aims-to-bridge-ai-cold-war" target="_blank" rel="noreferrer noopener">Nvidia Resumes H20 Shipments To China As Jensen Huang Meets Tr</a></li>
</ul>
Photo via Shutterstock

Earnings

Large Cap

BlackRock's AUM Jumps To $12.53 Trillion, Revenue Up 13%

Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) affirms FY2025 Adj EPS guidance from $2.03-$2.16 to $2.03-$2.16 vs $2.11 analyst estimate..

Guidance

Albertsons Companies Affirms FY2025 Adj EPS Guidance of $2.03-$2.16 vs $2.11 Est, Projects Identical Sales Growth In The Range Of 2%-2.75% (Previously 1.5%-2.5%)

CEG moves up over 8 points after Alert
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/14204300/Screenshot-2025-07-14-at-4.39.52%E2%80%AFPM-940x1024.png" alt="" class="wp-image-15809" /></figure>
Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:22 AM on July 14th, a significant trading signal occurred for Constellation Energy (CEG) as it demonstrated a Power Inflow at a price of $318.26. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Constellation's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Constellation's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for CEG,<a href="https://benzinga.grsm.io/register174"> Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like&nbsp; <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_July2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_July2025</a>
which are responsible for parts of the data within this article.
After Market Close UPDATE:
The price at the time of the Power Inflow was $318.26. The returns on the High price ($326.55) and Close price ($326.12) after the Power Inflow are respectively 2.6% and 2.5%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. They were close today but that is not always the case.
Past performance is not indicative of future results

Equities

Technicals

Opinion

Signals

Constellation Energy Rises 2.6% After Key Trading Signal

Albertsons Companies Announced The Next Quarterly Dividend Payment Of $0.15 Per Share To Be Paid On August 8

Nexxen International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) ("Nexxen" or the "Company"), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced it anticipates benefitting from the announcement that Vestel recently entered a strategic partnership with VIDAA, the world's second largest and fastest-growing smart TV platform.
Nexxen has a strategic partnership with VIDAA, which is set to expire at the end of 2026, and currently holds an approximately 2.439% ownership stake in the smart TV platform. In May 2025, Nexxen signed a non-binding Memorandum of Understanding ("MOU") with VIDAA, outlining the potential extension and expansion of their existing strategic partnership for multiple years beyond its current term, along with a possible increase in Nexxen's investment in the smart TV platform aimed at accelerating the expansion of VIDAA's smart TV footprint over the long term. The MOU is non-binding and remains subject to the ongoing negotiation and execution of definitive agreements, as well as customary closing conditions.
VIDAA announced that Vestel, one of Europe's largest connected TV ("CTV") manufacturers which produces CTVs for brands including Vestel, Toshiba, JVC, Telefunken and others through licensing agreements, recently entered a partnership with VIDAA through which VIDAA will serve as the smart TV operating system for Vestel's global CTV original equipment manufacturer ("OEM") base. VIDAA advised that the partnership is expected to expand VIDAA's CTV operating system reach, particularly in Europe, concurrently increasing the scale of its global ACR data.
The Company believes the agreement, as announced between VIDAA and Vestel, positively impacts all elements of Nexxen's long-term strategic partnership with VIDAA, including its exclusive access to VIDAA's global ACR data, exclusive ad monetization in select markets and Nexxen's existing European CTV footprint, enabled through its partnership with Hisense (the world's second largest CTV distributor and VIDAA's parent company) which also manufactures CTVs for Toshiba and other brands.
In addition, VIDAA advised that Vestel also invested in VIDAA at a valuation comparable to the valuation at which Nexxen closed its $25 million investment in the smart TV platform in August 2022.

NEXN

Nexxen Eyes Expansion of Smart TV Advertising Reach Through VIDAA-Vestel Deal and Ongoing Strategic Talks

Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference
Plus will also host an educational symposium with leading experts titled, "Reimagining Your Approach to Leptomeningeal Metastases"
HOUSTON, July 15, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=FM696Cq7hp4Qk6g8d9R8vSQmFOkgucFkoDxsJc31wcrfUxh3zue7aYuMopR5uHVvUpr2wK7Md6w9MDCpcWtOJdVz0932Ec-fzMkAdDAh_mI=">Plus Therapeutics, Inc.</a> (Nasdaq:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=yysOFmnPYkF13xx48n9vkk-wWVE3_rcIfRfKAOrOmjuKz_14EwAJ8hJw9p52RUuYmiRjdai4uxdUQrr753vXxQ==">PSTV</a>) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announces the oral presentation of its ReSPECT-LM clinical trial results and a sponsored educational symposium, at the upcoming SNO/ASCO CNS Metastases Conference on August 14-16, 2025, at the Baltimore Waterfront Marriott Hotel in Baltimore, MD.&nbsp;&nbsp;

PSTV

Plus Therapeutics Announces Oral Presentation Of ReSPECT-LM Clinical Trial Results And Sponsored Educational Symposium, At SNO/ASCO CNS Metastases Conference

Rosenblatt analyst Blair Abernethy initiates coverage on GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Buy rating and announces Price Target of $58.

Initiation

GTLB

Rosenblatt Initiates Coverage On GitLab with Buy Rating, Announces Price Target of $58

State Street Investment Management AUM Increased 17% To $5.1T, Fee Revenue Increased 11%

ABEO

Abeona Therapeutics Announced Activation Of The Newest Qualified Treatment Center For FDA-approved Zevaskyn (Prademagene Zamikeracel) Gene-modified Cellular Sheets

In a recent podcast, billionaire entrepreneur Mark Cuban pointed out a striking similarity between New York City mayoral candidate Zohran Mamdani and President Donald Trump, despite their differing political ideologies.
What Happened: On the &#8220;Pod Save America&#8221; podcast episode aired on July 13, Cuban, a billionaire entrepreneur, highlighted a common thread between Mamdani and Trump, without naming the NYC Mayoral candidate. Cuban pointed out that both Mamdani and Trump effectively centered their campaigns on issues that resonate with voters' everyday lives, regardless of whether their promises were realistic or achievable.
Cuban likened Mamdani&#8217;s approach to Trump&#8217;s campaign tactics, remarking, &#8220;This guy is walking in telling me he&#8217;s going to walk on water.&#8221; He likened the tactic to &#8220;Trump 101. Is it true? Does it matter?&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Mark Cuban Bluntly Criticizes Donald Trump and Democrats" width="500" height="281" src="https://www.youtube.com/embed/cWge2xxJ1o4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
&#8220;We&#8217;re cutting rents, right? We&#8217;re changing grocery stores. None of that shit has a chance. Doesn&#8217;t matter,&#8221; Cuban said, referring to some of Mamdani&#8217;s key proposals without naming him. 
Cuban further expressed skepticism towards campaign promises that lack concrete implementation plans, stating Mamdani&#8217;s promises were &#8216;analogous&#8217; to Trump&#8217;s pledge to have Mexico pay for a border wall, <a href="https://www.businessinsider.com/billionaire-mark-cuban-nyc-mayor-zohran-mamdani-2025-7">reported </a>Business Insider.
&#8220;That seems to be the path of least resistance to getting votes for any office,&#8221; Cuban told the publication. 
SEE ALSO: <a href="https://benzinga.com/crypto/cryptocurrency/25/07/46390887/xrp-surges-5-to-tap-3-how-soon-will-it-hit-all-time-highs" target="_blank" rel="noreferrer noopener">XRP Surges 5% To Tap $3: How Soon Will It Hit All-Time Highs? &#8211; Benzinga</a>
Why It Matters: Mamdani&#8217;s proposals have sparked significant debate in New York City. His plan to open five city-owned grocery stores, one in each borough, aims to address <a href="https://www.benzinga.com/news/topics/25/07/46262154/optics-over-results-new-yorks-zohran-mamdani-proposed-government-owned-grocery-stores-but-what-do-people-really-think-about-them">food insecurity</a> in areas with limited supermarket access. However, critics argue that the $60 million pilot project lacks clarity on execution and may be more of a political maneuver than a viable solution.
Additionally, Mamdani&#8217;s candidacy has <a href="https://www.benzinga.com/news/politics/25/07/46238084/ex-obama-treasury-secretary-jack-lew-sounds-alarm-on-nyc-under-zohran-mamdani-i-worry-deeply">drawn criticism</a> from centrist Democrats, including former Treasury Secretary Jack Lew, who expressed concerns about the city&#8217;s future under Mamdani&#8217;s leadership. Lew, a longtime New Yorker, voiced his worries about the impact of Mamdani&#8217;s policies on the city. 
Meanwhile, Trump has proposed a <a href="https://www.benzinga.com/news/politics/25/07/46312519/trump-mulls-federal-takeover-of-washington-dc-and-nyc-ahead-of-zohran-mamdanis-mayoral-bid-were-going-to-bring-new-york-back">federal takeover</a> of New York City, citing governance and crime concerns, further highlighting the contentious nature of the upcoming mayoral election. He also threated to cut funding for NYC if Mamdani didn&#8217;t do the right thing as a future mayor.
READ MORE:<a href="https://www.benzinga.com/news/sports/25/07/46383435/mark-cuban-calls-for-nba-veterans-exclusion-from-olympics-were-giving-all-these-guys-for-free-and-taking-the-injury-risk"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/sports/25/07/46383435/mark-cuban-calls-for-nba-veterans-exclusion-from-olympics-were-giving-all-these-guys-for-free-and-taking-the-injury-risk">Mark Cuban Calls for NBA Veterans&#8217; Exclusion From Olympics: &#8216;We&#8217;re Giving All These Guys for Free and Taking the Injury Risk&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Mark Cuban Refers To Zohran Mamdani As 'Trump 101,' Drawing Parallels Between Their Election Campaigns: 'This Guy Is...Telling Me He's Going To Walk On Water'

Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process
Neuronetics reiterates guidance for second quarter and full year 2025
MALVERN, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that Steven Pfanstiel has been appointed as the company's new Chief Financial Officer, effective July 15, 2025. Mr. Pfanstiel replaces Steve Furlong, who announced his intention to retire on March 31, 2026. Mr. Furlong will remain with the company, as Senior Advisor to the CEO, until the end of March 2026 to ensure a smooth transition.
In conjunction with this announcement, Neuronetics is reaffirming its guidance for the second quarter and full year 2025, driven by the ongoing successful integration of Greenbrook operations and continued progress across key growth drivers. The company remains well-positioned to achieve positive cash flow in the third quarter of 2025, marking a significant operational milestone in its path to sustained profitability.

STIM

Neuronetics Appoints Steven Pfanstiel As CFO, Effective July 15, 2025; Reaffirms Q2, FY25 Guidance Citing Integration Of Greenbrook Operations And Continued Progress Across Key Growth Drivers

Management

IOVA

Iovance Biotherapeutics Has Appointed Corleen Roche As Chief Financial Officer, Effective August 6

Offerings

Press Releases

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

Comments

Lucid Diagnostics

Lucid Diagnostics (LUCD) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL